A. A. Ribeiro

Clinical outcomes in allogeneic haematopoietic stem cell transplantation: A comparison between young and elderly patients. Observational study.

N. Hamerschlak, L. Kerbauy, Morgani Rodrigues, 2019, European journal of cancer care.

Haploidentical Transplantation with Post-Transplant Cyclophosphamide versus Unrelated Donor Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.

A. A. Ribeiro, L. Arcuri, Marina Tayla Mesquita Aguiar, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic hematopoietic stem cell transplant after intravenous busulfan and fludarabine conditioning

N. Hamerschlak, M. de Lima, M. Torres, 2011, Leukemia & lymphoma.

Axoval neuropathy as initial manifestation of primary amyloidosis: report of a case submitted to bone marrow transplantation.

O. Barsottini, N. Hamerschlak, A. Arantes, 2004, Arquivos de neuro-psiquiatria.

AXONAL NEUROPATHY AS INITIAL MANIFESTATION OF PRIMARY AMYLOIDOSIS Report of a case submitted to bone marrow transplantation

O. Barsottini, N. Hamerschlak, A. Arantes, 2004 .

Autologous stem-cell transplantation for multiple myeloma: a Brazilian institution experience in 15 years of follow-up.

N. Hamerschlak, J. Kutner, Morgani Rodrigues, 2011, Einstein.

Need for hemodialysis in patients undergoing hematopoietic stem cell transplantation: risk factors and survival in a retrospective cohort.

N. Hamerschlak, L. Kerbauy, E. Chapchap, 2022, Hematology, transfusion and cell therapy.

Pancreatic iron stores assessed by magnetic resonance imaging (MRI) in beta thalassemic patients.

A. Araújo, F. Kay, J. Wood, 2012, European journal of radiology.

Transplantation of Hematopoietic Stem Cells for Primary Immunodeficiencies in Brazil: Challenges in Treating Rare Diseases in Developing Countries

A. Gennery, V. Rocha, N. Hamerschlak, 2018, Journal of Clinical Immunology.

Targeted Marrow Irradiation Intensification of Reduced Intensity Fludarabine/Busulfan Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation.

R. Sékaly, M. Gallogly, N. Hamerschlak, 2022, Transplantation and cellular therapy.

Risk factors for adverse outcomes following haploidentical hematopoietic cell transplantation with posttransplant cyclophosphamide: a two-center analysis

N. Hamerschlak, L. Kerbauy, A. A. Ribeiro, 2021, Annals of Hematology.

Regulatory considerations for Cellular Therapy

A. Kondo, A. A. Ribeiro, 2022, JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY.

Imatinib Treated Chronic Myelogenous Leukemia Concomitant with Multiple Myeloma. Is There a Relationship

N. Hamerschlak, F. P. Santos, J. Kutner, 2010 .